SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 46 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $97,297,084 | +1.6% | 96,994,000 | 0.0% | 1.93% | -15.2% |
| Q4 2022 | $95,739,137 | +0.5% | 96,994,000 | 0.0% | 2.28% | +4.5% |
| Q3 2022 | $95,234,000 | +0.8% | 96,994,000 | 0.0% | 2.18% | +2.6% |
| Q2 2022 | $94,477,000 | -0.1% | 96,994,000 | +1.4% | 2.13% | +15.4% |
| Q1 2022 | $94,537,000 | +28.3% | 95,694,000 | +29.3% | 1.84% | +19.8% |
| Q4 2021 | $73,675,000 | +93.5% | 74,027,000 | +92.6% | 1.54% | +76.1% |
| Q3 2021 | $38,079,000 | +65.3% | 38,428,000 | +64.7% | 0.87% | +74.8% |
| Q2 2021 | $23,040,000 | – | 23,328,000 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 71,162 | $69,799,000 | 4.72% |
| ZAZOVE ASSOCIATES LLC | 27,692,000 | $27,021,000 | 2.38% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 61,727,000 | $60,252,000 | 1.17% |
| SHENKMAN CAPITAL MANAGEMENT INC | 7,637,000 | $7,524,000 | 0.85% |
| NN Investment Partners Holdings N.V. | 38,700,000 | $37,743,000 | 0.30% |
| CAMDEN ASSET MANAGEMENT L P /CA | 5,825,000 | $5,684,000 | 0.18% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 4,479,000 | $4,384,000 | 0.16% |
| Lombard Odier Asset Management (Europe) Ltd | 2,005,000 | $1,905,000 | 0.16% |
| PRUDENTIAL PLC | 41,809,000 | $40,973,000 | 0.12% |
| Calamos Advisors LLC | 22,303,000 | $21,829,000 | 0.12% |